Concepedia

Lyubov Efros

LE

3

Publications

162

Citations

3

H-Index

2002

Active since

Affiliations

AbbVie (United States)(Current)

Lyubov Efros is an author at AbbVie (United States) specializing in cerebral blood flow, ischemic stroke, and neuroscience.

Top concepts

Publications per year

2002–2013

3

Publications

3

HuEP5C7 as a Humanized Monoclonal Anti-E/P-Selectin Neurovascular Protective Strategy in a Blinded Placebo-Controlled Trial of Nonhuman Primate Stroke

J Mocco, Tanvir F. Choudhri, Judy Huang et al. · Circulation Research · 2002 · 82 citations · Full text

, , +23

Intermediate-affinity interleukin-2 receptor expression predicts CD56<sup>bright</sup> natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis

James P. Sheridan, Ying Zhang, Katherine Riester et al. · Multiple Sclerosis Journal · 2011 · 50 citations

Daclizumab reduces CD25 levels on T cells through monocyte-mediated trogocytosis

Y Zhang, Merriam McClellan, Lyubov Efros et al. · Multiple Sclerosis Journal · 2013 · 30 citations · Full text

Rows per page

1–3 of 3